EE05532B1 - Pürasolopürimidinoonühendit sisaldav farmatseutiline kompositsioon eesnäärme- suurenemuse ärahoidmiseks ja raviks - Google Patents
Pürasolopürimidinoonühendit sisaldav farmatseutiline kompositsioon eesnäärme- suurenemuse ärahoidmiseks ja raviksInfo
- Publication number
- EE05532B1 EE05532B1 EEP200800065A EEP200800065A EE05532B1 EE 05532 B1 EE05532 B1 EE 05532B1 EE P200800065 A EEP200800065 A EE P200800065A EE P200800065 A EEP200800065 A EE P200800065A EE 05532 B1 EE05532 B1 EE 05532B1
- Authority
- EE
- Estonia
- Prior art keywords
- preventing
- pharmaceutical composition
- composition containing
- treating prostate
- prostate enlargement
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/KR2006/001242 WO2007114534A1 (en) | 2006-04-04 | 2006-04-04 | Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE200800065A EE200800065A (et) | 2008-12-15 |
| EE05532B1 true EE05532B1 (et) | 2012-04-16 |
Family
ID=38563793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200800065A EE05532B1 (et) | 2006-04-04 | 2006-04-04 | Pürasolopürimidinoonühendit sisaldav farmatseutiline kompositsioon eesnäärme- suurenemuse ärahoidmiseks ja raviks |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8148386B2 (xx) |
| JP (1) | JP4975805B2 (xx) |
| AU (1) | AU2006341342B2 (xx) |
| BR (1) | BRPI0621588A2 (xx) |
| CA (1) | CA2647932C (xx) |
| EE (1) | EE05532B1 (xx) |
| IL (1) | IL194463A (xx) |
| MX (1) | MX2008012549A (xx) |
| NZ (1) | NZ571673A (xx) |
| WO (1) | WO2007114534A1 (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008100886A1 (en) * | 2007-02-12 | 2008-08-21 | Auspex Pharmaceuticals, Inc. | Preparation and use of deuterated udenafil analogues as highly selective pde5 modulators for the treatment of erectile dysfunction |
| AU2011278042B2 (en) * | 2010-07-15 | 2017-02-16 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating genitourinary system disorders |
| GB2495884B (en) * | 2010-07-15 | 2017-05-31 | Iliich Epshtein Oleg | A method of increasing the effect of an activated-potentiated form of an antibody |
| BR112019024300A2 (pt) * | 2017-05-22 | 2020-06-16 | Topadur Pharma Ag | Ativadores de guanilato ciclase solúvel com modo duplo de ação e inibidores da fosfodiesterase e usos dos mesmos |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9823102D0 (en) * | 1998-10-23 | 1998-12-16 | Pfizer Ltd | Pharmaceutically active compounds |
| KR100353014B1 (ko) * | 1998-11-11 | 2002-09-18 | 동아제약 주식회사 | 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물 |
| CA2475377A1 (en) * | 2002-02-07 | 2003-08-14 | Pfizer Inc. | Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome |
-
2006
- 2006-04-04 CA CA2647932A patent/CA2647932C/en not_active Expired - Fee Related
- 2006-04-04 NZ NZ571673A patent/NZ571673A/en unknown
- 2006-04-04 EE EEP200800065A patent/EE05532B1/xx unknown
- 2006-04-04 MX MX2008012549A patent/MX2008012549A/es active IP Right Grant
- 2006-04-04 BR BRPI0621588-2A patent/BRPI0621588A2/pt not_active Application Discontinuation
- 2006-04-04 AU AU2006341342A patent/AU2006341342B2/en active Active
- 2006-04-04 WO PCT/KR2006/001242 patent/WO2007114534A1/en not_active Ceased
- 2006-04-04 JP JP2009504098A patent/JP4975805B2/ja active Active
-
2008
- 2008-10-02 IL IL194463A patent/IL194463A/en active IP Right Grant
- 2008-11-24 US US12/244,432 patent/US8148386B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007114534A1 (en) | 2007-10-11 |
| EE200800065A (et) | 2008-12-15 |
| US8148386B2 (en) | 2012-04-03 |
| AU2006341342B2 (en) | 2010-05-20 |
| US20090099357A1 (en) | 2009-04-16 |
| JP2009532463A (ja) | 2009-09-10 |
| CA2647932C (en) | 2011-06-07 |
| AU2006341342A1 (en) | 2007-10-11 |
| IL194463A0 (en) | 2009-08-03 |
| MX2008012549A (es) | 2009-01-14 |
| JP4975805B2 (ja) | 2012-07-11 |
| CA2647932A1 (en) | 2007-10-11 |
| NZ571673A (en) | 2011-08-26 |
| BRPI0621588A2 (pt) | 2011-12-13 |
| IL194463A (en) | 2014-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0610514A2 (pt) | composto, composição farmacêutica, e, método de tratamento de um distúrbio | |
| BRPI0719393A2 (pt) | Composição farmacêutica | |
| DK2041139T3 (da) | Farmaceutiske forbindelser | |
| BRPI0819232A2 (pt) | composto heterocíclico e composição farmacêutica do mesmo | |
| ATE509842T1 (de) | Dosenende für eine dose und solch eine dose | |
| BRPI0809977A2 (pt) | Uso de um composto, compostos e composição farmacêutica que o contém | |
| BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
| ZA200808530B (en) | Pharmaceutical composition for external use | |
| HUS1400051I1 (hu) | Lurazidont tartalmazó gyógyászati készítmény | |
| ZA200808531B (en) | Pharmaceutical composition for external use | |
| PT2957278T (pt) | Uma composição estável compreendendo pthrp e utilizações da mesma | |
| ZA200803758B (en) | Oxazole compound and pharmaceutical composition | |
| ZA200809479B (en) | New pharmaceutical compounds | |
| ATE517619T1 (de) | Stabilisierte pharmazeutische zusammensetzung mit fesoterodin | |
| BRPI0917681A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI0809661A2 (pt) | Composição farmacêutica estabilizada contendo pregabalina | |
| BRPI0716698A2 (pt) | Composto, composição farmacêutica e uso de um composto | |
| DE602008005137D1 (de) | Chinolonverbindung und pharmazeutische zusammensetzung | |
| EP2069390A4 (en) | OPSIN STABILIZING COMPOUNDS AND METHODS OF USE | |
| EP2070919A4 (en) | SPIROCHINONE COMPOUND AND PHARMACEUTICAL COMPOSITION | |
| BRPI0914182A2 (pt) | composto, e, composição farmacêutica | |
| DK1886686T3 (da) | Farmaceutisk sammensætning indeholdende mometasonfuroat | |
| BRPI0720684A2 (pt) | composto, medicamento, composição farmacêutica que contém e uso do composto | |
| BRPI0607748A2 (pt) | composto, composição farmacêutica, e, método de tratamento de um distúrbio |